Biosimulation Market Size, Share, Trends, Growth 2032
Biosimulation Market By Product (Software and Services), By Application (Drug Development, Drug Discovery, and Others), and By End-User (Pharmaceutical & Biotechnology Companies, Contract Research Organizations, Regulatory Authorities, and Academic Research Institutions), And By Region - Global And Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, And Forecasts 2024 - 2032
| Market Size in 2023 | Market Forecast in 2032 | CAGR (in %) | Base Year |
|---|---|---|---|
| USD 2.67 Billion | USD 10.20 Billion | 16.05% | 2023 |
Table Of Content
- Chapter 1. Introduction
- 1.1. Report description and scope
- 1.2. Research scope
- 1.3. Research methodology
- 1.3.1. Market research process
- 1.3.2. Market research methodology
- Chapter 2. Executive Summary
- 2.1. Global Biosimulation Market, 2017-2025 (USD Billion)
- 2.2. Global Biosimulation Market: Snapshot
- Chapter 3. Biosimulation Market - Industry Dynamics
- 3.1. Introduction
- 3.2. Market drivers
- 3.2.1. Global Biosimulation Market drivers: Impact analysis
- 3.2.2. Increase in R&D Investments in Pharmaceutical and Biotechnology Industries
- 3.2.3. Growing Adoption of Biosimulation Software By Regulatory Bodies
- 3.2.4. Technologically Advanced QSP Systems
- 3.3. Market Restraints
- 3.3.1. Global Biosimulation Market restraints: Impact analysis
- 3.3.2. High product cost
- 3.3.3. Lack of Standardization
- 3.4. Opportunities
- 3.4.1. Emerging Applications
- 3.4.2. Increased Use of Personalized Medicines
- 3.4.3. Use of Biosimulation Solution for Pediatric Drug Development
- 3.5. Porter's Five Forces analysis
- 3.6. Market attractiveness analysis
- 3.6.1. Market attractiveness analysis, by product
- 3.6.2. Market attractiveness analysis, by application
- 3.6.3. Market attractiveness analysis, by end-user
- 3.6.4. Market attractiveness analysis, by region
- Chapter 4. Global Biosimulation Market - Competitive Landscape
- 4.1. Company Market Share Analysis
- 4.1.1. Global Biosimulation Market: company market share, 2018
- 4.2. Strategic Development
- 4.2.1. Acquisitions & Mergers
- 4.2.2. New Therapy Launch
- 4.2.3. Agreements, Partnerships, Collaborations, and Joint Ventures
- 4.2.4. Research and Development and Regional Expansion
- 4.3. Price Trend Analysis
- 4.4. Technology Portfolio
- 4.1. Company Market Share Analysis
- Chapter 5. Global Biosimulation Market - Product Analysis
- 5.1. Global Biosimulation Market: Product overview
- 5.1.1. Global Biosimulation Market revenue share, by product, 2018 and 2025
- 5.2. Software
- 5.2.1. Global Software Market, 2017-2025 (USD Billion)
- 5.3. Services
- 5.3.1. Global Services market, 2017-2025 (USD Billion)
- 5.3.2. Global In-house Services market, 2017-2025 (USD Billion)
- 5.3.3. Global Contract Services market, 2017-2025 (USD Billion)
- 5.1. Global Biosimulation Market: Product overview
- Chapter 6. Global Biosimulation Market - Application Analysis
- 6.1. Global Biosimulation Market: Application overview
- 6.1.1. Global Biosimulation Market revenue share, by application, 2017- 2025
- 6.2. Drug Development
- 6.2.1. Global Biosimulation Market for Drug Development, 2017-2025 (USD Billion)
- 6.3. Drug Discovery
- 6.3.1. Global Biosimulation Market for Drug Discovery, 2017-2025 (USD Billion)
- 6.4. Others
- 6.4.1. Global Biosimulation Market for Others, 2017-2025 (USD Billion)
- 6.1. Global Biosimulation Market: Application overview
- Chapter 7. Global Biosimulation Market - End-user Analysis
- 7.1. Global Biosimulation Market: End-user overview
- 7.1.1. Global Biosimulation Market revenue share, by end-user, 2017 and 2025
- 7.2. Pharmaceutical & Biotechnology Companies
- 7.2.1. Global Biosimulation Market for Pharmaceutical & Biotechnology Companies, 2017-2025 (USD Billion)
- 7.3. Contract Research Organizations
- 7.3.1. Global Biosimulation Market for Contract Research Organizations, 2017-2025 (USD Billion)
- 7.4. Regulatory Authorities
- 7.4.1. Global Biosimulation Market for Regulatory Authorities, 2017-2025 (USD Billion)
- 7.5. Academic Research Institutions
- 7.5.1. Global Biosimulation Market for Academic Research Institutions, 2017-2025 (USD Billion)
- 7.1. Global Biosimulation Market: End-user overview
- Chapter 8. Global Biosimulation Market - Regional Analysis
- 8.1. Global Biosimulation Market: Regional overview
- 8.1.1. Global Biosimulation Market revenue share, by region, 2017 and 2025
- 8.2. North America
- 8.2.1. North America Biosimulation Market revenue, by product, 2017-2025 (USD Billion)
- 8.2.2. North America Biosimulation Market revenue, by application, 2017-2025 (USD Billion)
- 8.2.3. North America Biosimulation Market revenue, by end-user, 2017-2025 (USD Billion)
- 8.2.4. The U.S.
- 8.2.4.1. The U.S. Biosimulation Market revenue, by product, 2017-2025 (USD Billion)
- 8.2.4.2. The U.S. Biosimulation Market revenue, by application, 2017-2025 (USD Billion)
- 8.2.4.3. The U.S. Biosimulation Market revenue, by end-user, 2017-2025 (USD Billion)
- 8.2.5. Canada
- 8.2.5.1. Canada Biosimulation Market revenue, by product, 2017-2025 (USD Billion)
- 8.2.5.2. Canada Biosimulation Market revenue, by application, 2017-2025 (USD Billion)
- 8.2.5.3. Canada Biosimulation Market revenue, by end-user, 2017-2025 (USD Billion)
- 8.3. Europe
- 8.3.1. Europe Biosimulation Market revenue, by product, 2017-2025 (USD Billion)
- 8.3.2. Europe Biosimulation Market revenue, by application, 2017-2025 (USD Billion)
- 8.3.3. Europe Biosimulation Market revenue, by end-user, 2017-2025 (USD Billion)
- 8.3.4. Germany
- 8.3.4.1. Germany Biosimulation Market revenue, by product, 2017-2025 (USD Billion)
- 8.3.4.2. Germany Biosimulation Market revenue, by application, 2017-2025 (USD Billion)
- 8.3.4.3. Germany Biosimulation Market revenue, by end-user, 2017-2025 (USD Billion)
- 8.3.5. France
- 8.3.5.1. France Biosimulation Market revenue, by product, 2017-2025 (USD Billion)
- 8.3.5.2. France Biosimulation Market revenue, by application, 2017-2025 (USD Billion)
- 8.3.5.3. France Biosimulation Market revenue, by end-user, 2017-2025 (USD Billion)
- 8.3.6. UK
- 8.3.6.1. UK Biosimulation Market revenue, by product, 2017-2025 (USD Billion)
- 8.3.6.2. UK Biosimulation Market revenue, by application, 2017-2025 (USD Billion)
- 8.3.6.3. UK Biosimulation Market revenue, by end-user, 2017-2025 (USD Billion)
- 8.3.7. Rest of Europe
- 8.3.7.1. Rest of Europe Biosimulation Market revenue, by product, 2017-2025 (USD Billion)
- 8.3.7.2. Rest of Europe Biosimulation Market revenue, by application, 2017-2025 (USD Billion)
- 8.3.7.3. Rest of Europe Biosimulation Market revenue, by end-user, 2017-2025 (USD Billion)
- 8.4. Asia Pacific
- 8.4.1. Asia Pacific Biosimulation Market revenue, by product, 2017-2025 (USD Billion)
- 8.4.2. Asia Pacific Biosimulation Market revenue, by application, 2017-2025 (USD Billion)
- 8.4.3. Asia Pacific Biosimulation Market revenue, by end-user, 2017-2025 (USD Billion)
- 8.4.4. China
- 8.4.4.1. China Biosimulation Market revenue, by product, 2017-2025 (USD Billion)
- 8.4.4.2. China Biosimulation Market revenue, by application, 2017-2025 (USD Billion)
- 8.4.4.3. China Biosimulation Market revenue, by end-user, 2017-2025 (USD Billion)
- 8.4.5. Japan
- 8.4.5.1. Japan Biosimulation Market revenue, by product, 2017-2025 (USD Billion)
- 8.4.5.2. Japan Biosimulation Market revenue, by application, 2017-2025 (USD Billion)
- 8.4.5.3. Japan Biosimulation Market revenue, by end-user, 2017-2025 (USD Billion)
- 8.4.6. India
- 8.4.6.1. India Biosimulation Market revenue, by product, 2017-2025 (USD Billion)
- 8.4.6.2. India Biosimulation Market revenue, by application, 2017-2025 (USD Billion)
- 8.4.6.3. India Biosimulation Market revenue, by end-user, 2017-2025 (USD Billion)
- 8.4.7. Rest of Asia Pacific
- 8.4.7.1. Rest of Asia Pacific Biosimulation Market revenue, by product, 2017-2025 (USD Billion)
- 8.4.7.2. Rest of Asia Pacific Biosimulation Market revenue, by application, 2017-2025 (USD Billion)
- 8.4.7.3. Rest of Asia Pacific Biosimulation Market revenue, by end-user, 2017-2025 (USD Billion)
- 8.5. Latin America
- 8.5.1. Latin America Biosimulation Market revenue, by product, 2017-2025 (USD Billion)
- 8.5.2. Latin America Biosimulation Market revenue, by application, 2017-2025 (USD Billion)
- 8.5.3. Latin America Biosimulation Market revenue, by end-user, 2017-2025 (USD Billion)
- 8.5.4. Brazil
- 8.5.4.1. Brazil Biosimulation Market revenue, by product, 2017-2025 (USD Billion)
- 8.5.4.2. Brazil Biosimulation Market revenue, by application, 2017-2025 (USD Billion)
- 8.5.4.3. Brazil Biosimulation Market revenue, by end-user, 2017-2025 (USD Billion)
- 8.5.5. Rest of Latin America
- 8.5.5.1. Rest of Latin America Biosimulation Market revenue, by product, 2017-2025 (USD Billion)
- 8.5.5.2. Rest of Latin America Biosimulation Market revenue, by application, 2017-2025 (USD Billion)
- 8.5.5.3. Rest of Latin America Biosimulation Market revenue, by end-user, 2017-2025 (USD Billion)
- 8.6. The Middle East and Africa
- 8.6.1. The Middle East and Africa Biosimulation Market revenue, by product, 2017-2025 (USD Billion)
- 8.6.2. The Middle East and Africa Biosimulation Market revenue, by application, 2017-2025 (USD Billion)
- 8.6.3. The Middle East and Africa Biosimulation Market revenue, by end-user, 2017-2025 (USD Billion)
- 8.1. Global Biosimulation Market: Regional overview
- Chapter 9. Company Profile
- 9.1. Dassault Systèmes SE
- 9.1.1. Overview
- 9.1.2. Financials
- 9.1.3. Therapy portfolio
- 9.1.4. Business strategy
- 9.1.5. Recent developments
- 9.2. Certara USA, Inc.
- 9.2.1. Overview
- 9.2.2. Financials
- 9.2.3. Therapy portfolio
- 9.2.4. Business strategy
- 9.2.5. Recent developments
- 9.3. Chemical Computing Group
- 9.3.1. Overview
- 9.3.2. Financials
- 9.3.3. Therapy portfolio
- 9.3.4. Business strategy
- 9.3.5. Recent developments
- 9.4. Physiomics
- 9.4.1. Overview
- 9.4.2. Financials
- 9.4.3. Therapy portfolio
- 9.4.4. Business strategy
- 9.4.5. Recent developments
- 9.5. In Silico Biosciences
- 9.5.1. Overview
- 9.5.2. Financials
- 9.5.3. Therapy portfolio
- 9.5.4. Business strategy
- 9.5.5. Recent developments
- 9.6. INOSIM Software
- 9.6.1. Overview
- 9.6.2. Financials
- 9.6.3. Therapy portfolio
- 9.6.4. Business strategy
- 9.6.5. Recent developments
- 9.7. Advanced Chemistry Development, Inc.
- 9.7.1. Overview
- 9.7.2. Financials
- 9.7.3. Therapy portfolio
- 9.7.4. Business strategy
- 9.7.5. Recent developments
- 9.8. Schrodinger, Inc.
- 9.8.1. Overview
- 9.8.2. Financials
- 9.8.3. Therapy portfolio
- 9.8.4. Business strategy
- 9.8.5. Recent developments
- 9.9. Genedata AG
- 9.9.1. Overview
- 9.9.2. Financials
- 9.9.3. Therapy portfolio
- 9.9.4. Business strategy
- 9.9.5. Recent developments
- 9.10. Rhenovia Pharma Ltd.
- 9.10.1. Overview
- 9.10.2. Financials
- 9.10.3. Therapy portfolio
- 9.10.4. Business strategy
- 9.10.5. Recent developments
- 9.1. Dassault Systèmes SE
Table Of Figures
List of Figures
1. Market research process
2. Market research methodology
3. Global Biosimulation Market revenue, 2017–2025 (USD Billion)
4. Porter’s Five Forces analysis
5. Biosimulation Market attractiveness analysis, by product
6. Biosimulation: Market attractiveness analysis, by application
7. Biosimulation: Market attractiveness analysis, by end-user
8. Biosimulation: Market attractiveness analysis, by region
9. Company market share analysis, 2018
10. Global Biosimulation Market revenue share by product, 2018 and 2025
11. Global Software Market, 2017–2025 (USD Billion)
12. Global Services market, 2017–2025 (USD Billion)
13. Global Biosimulation Market revenue share by application, 2017 and 2025
14. Global Biosimulation Market for Drug Development, 2017–2025 (USD Billion)
15. Global Biosimulation Market for Drug Discovery, 2017–2025 (USD Billion)
16. Global Biosimulation Market for Others, 2017–2025 (USD Billion)
17. Global Biosimulation Market revenue share by end-user, 2017 and 2025
18. Global Biosimulation Market for Pharmaceutical & Biotechnology Companies, 2017–2025 (USD Billion)
19. Global Biosimulation Market for Contract Research Organizations, 2017–2025 (USD Billion)
20. Global Biosimulation Market for Regulatory Authorities, 2017–2025 (USD Billion)
21. Global Biosimulation Market for Academic Research Institutions, 2017–2025 (USD Billion)
Table Of Tables
List of Tables
1. Biosimulation Market: Market Snapshot
2. Drivers of global Biosimulation Market: Impact analysis
3. Restraints of global Biosimulation Market: Impact analysis
4. North America Biosimulation Market revenue, by product, 2017–2025 (USD Billion)
5. North America Biosimulation Market revenue, by application, 2017–2025 (USD Billion)
6. North America Biosimulation Market revenue, by end-user, 2017–2025 (USD Billion)
7. The U.S. Biosimulation Market revenue, by product, 2017–2025 (USD Billion)
8. The U.S. Biosimulation Market revenue, by application, 2017–2025 (USD Billion)
9. The U.S. Biosimulation Market revenue, by end-user, 2017–2025 (USD Billion)
10. Canada Biosimulation Market revenue, by product, 2017–2025 (USD Billion)
11. Canada Biosimulation Market revenue, by application, 2017–2025 (USD Billion)
12. Canada Biosimulation Market revenue, by end-user, 2017–2025 (USD Billion)
13. Europe Biosimulation Market revenue, by product, 2017–2025 (USD Billion)
14. Europe Biosimulation Market revenue, by application, 2017–2025 (USD Billion)
15. Europe Biosimulation Market revenue, by end-user, 2017–2025 (USD Billion)
16. UK Biosimulation Market revenue, by product, 2017–2025 (USD Billion)
17. UK Biosimulation Market revenue, by application, 2017–2025 (USD Billion)
18. UK Biosimulation Market revenue, by end-user, 2017–2025 (USD Billion)
19. Germany Biosimulation Market revenue, by product, 2017–2025 (USD Billion)
20. Germany Biosimulation Market revenue, by application, 2017–2025 (USD Billion)
21. Germany Biosimulation Market revenue, by end-user, 2017–2025 (USD Billion)
22. France Biosimulation Market revenue, by product, 2017–2025 (USD Billion)
23. France Biosimulation Market revenue, by application, 2017–2025 (USD Billion)
24. France Biosimulation Market revenue, by end-user, 2017–2025 (USD Billion)
25. Rest of Europe Biosimulation Market revenue, by product, 2017–2025 (USD Billion)
26. Rest of Europe Biosimulation Market revenue, by application, 2017–2025 (USD Billion)
27. Rest of Europe Biosimulation Market revenue, by end-user, 2017–2025 (USD Billion)
28. Asia Pacific Biosimulation Market revenue, by product, 2017–2025 (USD Billion)
29. Asia Pacific Biosimulation Market revenue, by application, 2017–2025 (USD Billion)
30. Asia Pacific Biosimulation Market revenue, by end-user, 2017–2025 (USD Billion)
31. China Biosimulation Market revenue, by product, 2017–2025 (USD Billion)
32. China Biosimulation Market revenue, by application, 2017–2025 (USD Billion)
33. China Biosimulation Market revenue, by end-user, 2017–2025 (USD Billion)
34. Japan Biosimulation Market revenue, by product, 2017–2025 (USD Billion)
35. Japan Biosimulation Market revenue, by application, 2017–2025 (USD Billion)
36. Japan Biosimulation Market revenue, by end-user, 2017–2025 (USD Billion)
37. India Biosimulation Market revenue, by product, 2017–2025 (USD Billion)
38. India Biosimulation Market revenue, by application, 2017–2025 (USD Billion)
39. India Biosimulation Market revenue, by end-user, 2017–2025 (USD Billion)
40. Rest of Asia Pacific Biosimulation Market revenue, by product, 2017–2025 (USD Billion)
41. Rest of Asia Pacific Biosimulation Market revenue, by application, 2017–2025 (USD Billion)
42. Rest of Asia Pacific Biosimulation Market revenue, by end-user, 2017–2025 (USD Billion)
43. Latin America Biosimulation Market revenue, by product, 2017–2025 (USD Billion)
44. Latin America Biosimulation Market revenue, by application, 2017–2025 (USD Billion)
45. Latin America Biosimulation Market revenue, by end-user, 2017–2025 (USD Billion)
46. Brazil Biosimulation Market revenue, by product, 2017–2025 (USD Billion)
47. Brazil Biosimulation Market revenue, by application, 2017–2025 (USD Billion)
48. Brazil Biosimulation Market revenue, by end-user, 2017–2025 (USD Billion)
49. Rest of Latin America Biosimulation Market revenue, by product, 2017–2025 (USD Billion)
50. Rest of Latin America Biosimulation Market revenue, by application, 2017–2025 (USD Billion)
51. Rest of Latin America Biosimulation Market revenue, by end-user, 2017–2025 (USD Billion)
52. The Middle East and Africa Biosimulation Market revenue, by product, 2017–2025 (USD Billion)
53. The Middle East and Africa Biosimulation Market revenue, by application, 2017–2025 (USD Billion)
54. The Middle East and Africa Biosimulation Market revenue, by end-user, 2017–2025 (USD Billion)
Methodology
FrequentlyAsked Questions
Biosimulation, also known as computational biology or in silico biology, is a multidisciplinary discipline that studies biological processes, systems, and phenomena through the use of computer simulations and mathematical models. By incorporating principles derived from computer science, mathematics, biology, and physics, this approach analyzes and forecasts the behavior of biological systems.
Biosimulation market expansion is propelled by ongoing developments in computational methods, including algorithms designed to model biological systems, enhanced computing power, and improved simulation software. These developments improve the precision, effectiveness, and expandability of biosimulation methods, thereby expanding their utility and accessibility in a wide range of scientific fields.
The global biosimulation market size was worth around USD 2.67 billion in 2023 and is predicted to grow to around USD 10.20 billion by 2032.
The global biosimulation market with a compound annual growth rate (CAGR) of roughly 16.05% between 2024 and 2032.
The regional segmentation comprises present and projected demand for the following regions: North America, Europe, Asia-Pacific, Latin America, the Middle East, and Africa. Additionally, it is subdivided into significant countries such as the United States, Germany, France, United Kingdom, China, Japan, India, and Brazil.
Some key players of the global biosimulation market include Dassault Systèmes SE, Certara USA, Inc., Chemical Computing Group, Physiomics, In Silico Biosciences, INOSIM Software, Advanced Chemistry Development, Inc., Schrodinger, Inc., Genedata AG, and Rhenovia Pharma Ltd., among others.
RelatedNews
Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651
3rd Floor,
Mrunal Paradise, Opp Maharaja Hotel,
Pimple Gurav, Pune 411061,
Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008
US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com
We have secured system to process your transaction.
Our support available to help you 24 hours a day, five days a week.
Monday - Friday: 9AM - 6PM
Saturday - Sunday: Closed